Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D016604 |
Aflatoxin B1 |
Aflatoxin B1 affects the expression of GOLGA8A protein | affects expression | 20106945
|
C068073 |
Am 580 |
Am 580 results in decreased expression of GOLGA8A mRNA | decreases expression | 16982809
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in decreased expression of GOLGA8A mRNA | decreases expression | 20106945
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of GOLGA8A mRNA | increases expression | 20018196
|
D002945 |
Cisplatin |
GOLGA8A protein affects the susceptibility to Cisplatin | affects response to substance | 16217747
|
D004958 |
Estradiol |
Estradiol results in increased expression of GOLGA8A mRNA | increases expression | 20106945
|
D005472 |
Fluorouracil |
GOLGA8A mRNA results in increased susceptibility to [Leucovorin co-treated with Fluorouracil co-treated with irinotecan] | affects cotreatment|increases response to substance | 17327601
|
D002955 |
Leucovorin |
GOLGA8A mRNA results in increased susceptibility to [Leucovorin co-treated with Fluorouracil co-treated with irinotecan] | affects cotreatment|increases response to substance | 17327601
|
C051890 |
irinotecan |
GOLGA8A mRNA results in increased susceptibility to [Leucovorin co-treated with Fluorouracil co-treated with irinotecan] | affects cotreatment|increases response to substance | 17327601
|
C089730 |
rosiglitazone |
rosiglitazone results in decreased expression of GOLGA8A mRNA | decreases expression | 16982809
|
D012643 |
Selenium |
[Selenium co-treated with Vitamin E] results in increased expression of GOLGA8A mRNA | affects cotreatment|increases expression | 19244175
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of GOLGA8A mRNA | decreases expression | 20106945
|
D014810 |
Vitamin E |
[Selenium co-treated with Vitamin E] results in increased expression of GOLGA8A mRNA | affects cotreatment|increases expression | 19244175
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
2.96 | 15322242 14514962 11752688 |
MESH:D058186 |
Acute Kidney Injury |
|
Cisplatin |
4.04 | 17670903 15814532 12690470 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
10.37 | 20464547 20127859 |
MESH:D000230 |
Adenocarcinoma |
|
Cisplatin |
10.37 | 11798837 17638652 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
10.37 | 11473722 |
MESH:D000230 |
Adenocarcinoma |
|
Fluorouracil |
10.37 | 17638652 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
2.70 | 6695378 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.49 | 16835633 |
MESH:D000544 |
Alzheimer Disease |
|
rosiglitazone |
2.87 | 19621015 |
MESH:D000740 |
Anemia |
|
Fluorouracil |
8.94 | 17963324 15504547 16511603 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
8.94 | 11748828 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
4.18 | 19183758 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
3.12 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.92 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.81 | 15746008 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Cisplatin |
5.02 | 14601052 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
2.36 | 20146248 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Cisplatin |
2.36 | 19526202 18382427 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
2.36 | 12948864 16675129 17289903 17261762 17018787 14630087 19861407 18497071 |
MESH:D001943 |
Breast Neoplasms |
|
Fluorouracil |
2.36 | 18608205 16110121 18357371 15136595 16595493 19217205 16557594 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
2.36 | 20435547 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.58 | 16111702 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Vitamin E |
4.03 | 16050911 |
MESH:D002276 |
Carcinoid Tumor |
|
Fluorouracil |
4.80 | 16051944 |
MESH:D002277 |
Carcinoma |
|
Fluorouracil |
8.40 | 17121937 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
8.40 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Aflatoxin B1 |
6.72 | 12907637 21507988 12619106 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Cisplatin |
6.72 | 17982673 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
6.72 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Fluorouracil |
6.72 | 17045692 16799960 16332177 18930000 17971768 17088986 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
Cisplatin |
3.06 | 12023789 16685392 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Fluorouracil |
3.05 | 18695887 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
7.73 | 20419170 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Cisplatin |
7.73 | 17066447 18337622 6189445 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Fluorouracil |
7.73 | 16757204 16280240 18986760 17066447 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.41 | 18850075 18670907 16120746 |
MESH:D002386 |
Cataract |
|
Am 580 |
4.39 | 17460283 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
6.83 | 20889678 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
6.83 | 18566989 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.23 | 16835633 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.13 | 15340226 12621046 8697196 16354765 15668235 |
MESH:D003092 |
Colitis |
|
Am 580 |
10.31 | 17035595 |
MESH:D003092 |
Colitis |
|
Selenium |
10.31 | 17936198 |
MESH:D003110 |
Colonic Neoplasms |
|
Fluorouracil |
4.01 | 16340194 16510598 18772588 15001691 17287894 17725105 17172411 17018589 17016597 17169374 |
MESH:D003110 |
Colonic Neoplasms |
|
irinotecan |
4.01 | 17725105 17287894 |
MESH:D015179 |
Colorectal Neoplasms |
|
Cisplatin |
4.97 | 15273666 |
MESH:D015179 |
Colorectal Neoplasms |
|
Fluorouracil |
4.97 | 14970324 16282729 17255274 15148649 15289873 17594712 18448328 18383874 18288408 16524972 18949393 18802399 17016601 16303861 17094418 17695437 16391804 17401013 20501625 16331619 18509181 17454858 |
MESH:D015179 |
Colorectal Neoplasms |
|
irinotecan |
4.97 | 17454858 16391804 15273666 18259882 16303861 17159606 18509181 |
MESH:D015179 |
Colorectal Neoplasms |
|
Leucovorin |
4.97 | 17594712 16303861 17255274 20501625 17454858 17401013 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.13 | 14669216 17141729 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Leucovorin |
4.04 | 16925845 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
4.04 | 10048152 20055451 15322242 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Vitamin E |
4.04 | 19769572 |
MESH:D007644 |
Darier Disease |
|
Fluorouracil |
4.91 | 16733453 |
MESH:D003920 |
Diabetes Mellitus |
|
rosiglitazone |
4.37 | 17446233 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
rosiglitazone |
4.56 | 12642470 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
4.56 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
3.48 | 19279558 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Selenium |
3.84 | 15131321 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
3.84 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Cisplatin |
8.38 | 12649298 12231392 15033597 19839026 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
8.38 | 11462148 |
MESH:C538011 |
Eales disease |
|
Vitamin E |
4.84 | 9068938 |
MESH:D004487 |
Edema |
|
rosiglitazone |
7.24 | 12083418 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
7.24 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.04 | 15322242 18230668 16714409 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
3.03 | 11473722 18566989 19148513 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.10 | 10568697 9294722 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
10.59 | 20426865 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
10.59 | 16530937 |
MESH:D004938 |
Esophageal Neoplasms |
|
Cisplatin |
10.59 | 16481741 15173087 17638652 15464296 16785472 |
MESH:D004938 |
Esophageal Neoplasms |
|
Fluorouracil |
10.59 | 16337965 16785472 15173087 16481741 17638652 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.07 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
rosiglitazone |
4.01 | 19196556 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.56 | 11858732 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
3.05 | 20067830 |
MESH:D005910 |
Glioma |
|
Fluorouracil |
2.90 | 16145905 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.73 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Cisplatin |
8.17 | 15464296 15102660 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Fluorouracil |
8.17 | 15162350 18337622 15102660 |
MESH:D034381 |
Hearing Loss |
|
Cisplatin |
4.37 | 19898482 |
MESH:D006319 |
Hearing Loss, Sensorineural |
|
Cisplatin |
4.49 | 15464296 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
11.34 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
11.34 | 11294989 10048152 |
MESH:D006330 |
Heart Defects, Congenital |
|
Vitamin E |
11.34 | 16080930 |
MESH:D006333 |
Heart Failure |
|
Selenium |
3.12 | 17162251 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.42 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
3.00 | 15340226 16120746 12621046 |
MESH:D006548 |
Hernia, Diaphragmatic |
|
Vitamin E |
2.73 | 16490937 16863852 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
5.17 | 15709030 |
MESH:D006689 |
Hodgkin Disease |
|
Cisplatin |
3.66 | 16200630 16170182 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
10.50 | 17088409 |
MESH:D019584 |
Hot Flashes |
|
Vitamin E |
10.50 | 14716179 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.18 | 16959395 18606429 16354765 8697196 15340226 |
MESH:D006930 |
Hyperalgesia |
|
rosiglitazone |
3.98 | 12083418 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
1.93 | 18670907 18850075 |
MESH:D007249 |
Inflammation |
|
rosiglitazone |
5.30 | 12083418 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
5.30 | 12878042 12200463 |
MESH:D007251 |
Influenza, Human |
|
Selenium |
11.41 | 16624496 |
MESH:D007251 |
Influenza, Human |
|
Vitamin E |
11.41 | 16624496 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
7.80 | 16627594 16393666 |
MESH:D007333 |
Insulin Resistance |
|
rosiglitazone |
7.80 | 16306350 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.42 | 16580747 |
MESH:D007673 |
Kidney Cortex Necrosis |
|
Cisplatin |
5.27 | 15464296 |
MESH:D007674 |
Kidney Diseases |
|
Cisplatin |
10.44 | 12231392 12649298 15190930 19839026 18289764 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
10.44 | 15618244 |
MESH:D007674 |
Kidney Diseases |
|
Vitamin E |
10.44 | 12488133 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Selenium |
3.97 | 16518626 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
7.71 | 15610895 |
MESH:D007680 |
Kidney Neoplasms |
|
Fluorouracil |
7.71 | 16985049 |
MESH:D007683 |
Kidney Tubular Necrosis, Acute |
|
Cisplatin |
4.93 | 11231351 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
5.05 | 14716833 14659978 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
rosiglitazone |
5.05 | 15980055 17347453 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
5.05 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Vitamin E |
5.05 | 16169303 |
MESH:D008113 |
Liver Neoplasms |
|
Aflatoxin B1 |
10.94 | 9163691 15890375 2125692 18177683 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
10.94 | 21137059 20195826 |
MESH:D008113 |
Liver Neoplasms |
|
Fluorouracil |
10.94 | 15113037 16603448 17045692 18383874 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
10.94 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Aflatoxin B1 |
5.97 | 8603461 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
5.97 | 12151625 |
MESH:D008171 |
Lung Diseases |
|
Vitamin E |
3.23 | 16863852 |
MESH:D008175 |
Lung Neoplasms |
|
Aflatoxin B1 |
8.68 | 14755239 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
8.68 | 18569708 6695378 18816296 20869020 20464547 20135361 20064080 18520028 17053015 |
MESH:D008175 |
Lung Neoplasms |
|
Cisplatin |
8.68 | 6189445 17225452 11798837 |
MESH:D008175 |
Lung Neoplasms |
|
Fluorouracil |
8.68 | 15246190 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
8.68 | 11884234 19555203 |
MESH:D008175 |
Lung Neoplasms |
|
Vitamin E |
8.68 | 11062179 |
MESH:D008178 |
Lupus Erythematosus, Cutaneous |
|
Fluorouracil |
4.91 | 15086387 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
10.36 | 17203775 11807958 11408345 16891317 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
rosiglitazone |
10.36 | 16827153 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Selenium |
10.36 | 15318939 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
4.62 | 19453300 |
MESH:D008545 |
Melanoma |
|
Cisplatin |
2.48 | 12374674 16248763 18332650 15577323 18176117 17761969 12393984 17023156 11135225 16809738 12883367 18505091 16432458 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Cisplatin |
4.89 | 15990972 |
MESH:D008654 |
Mesothelioma |
|
Cisplatin |
6.46 | 17638057 |
MESH:D008654 |
Mesothelioma |
|
Selenium |
6.46 | 15107826 |
MESH:D024821 |
Metabolic Syndrome X |
|
rosiglitazone |
4.44 | 17261469 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
8.74 | 16381670 |
MESH:D009062 |
Mouth Neoplasms |
|
Fluorouracil |
8.74 | 16757204 18986760 |
MESH:D052016 |
Mucositis |
|
irinotecan |
5.12 | 17159606 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.08 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
3.34 | 16810080 |
MESH:D009362 |
Neoplasm Metastasis |
|
irinotecan |
3.20 | 18259882 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
8.58 | 11141357 |
MESH:D009369 |
Neoplasms |
|
Cisplatin |
8.58 | 16773208 |
MESH:D009369 |
Neoplasms |
|
Fluorouracil |
8.58 | 18239605 18600527 16928823 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
3.85 | 17289903 |
MESH:D009395 |
Nephritis, Interstitial |
|
Cisplatin |
4.63 | 15464296 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
9.78 | 16427766 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
9.78 | 14600291 |
MESH:D009447 |
Neuroblastoma |
|
Cisplatin |
7.35 | 8761367 |
MESH:D009447 |
Neuroblastoma |
|
irinotecan |
7.35 | 8761367 |
MESH:D017599 |
Neuroectodermal Tumors |
|
Cisplatin |
11.86 | 8761367 |
MESH:D017599 |
Neuroectodermal Tumors |
|
irinotecan |
11.86 | 8761367 |
MESH:D020258 |
Neurotoxicity Syndromes |
|
Fluorouracil |
3.49 | 16436463 |
MESH:D010051 |
Ovarian Neoplasms |
|
Cisplatin |
5.08 | 19769630 15464296 17225452 6897625 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
5.08 | 19401270 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Cisplatin |
5.62 | 19003803 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Fluorouracil |
5.62 | 16929163 16500647 19003803 15113037 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.38 | 12520081 |
MESH:D010523 |
Peripheral Nervous System Diseases |
|
Cisplatin |
4.40 | 15464296 |
MESH:D010954 |
Plasmacytoma |
|
Selenium |
5.02 | 15087411 |
MESH:D010997 |
Pleural Neoplasms |
|
Cisplatin |
5.48 | 17638057 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.65 | 18163543 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.31 | 11399792 11896295 11222880 11118676 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
3.97 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
2.05 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
2.05 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Fluorouracil |
2.05 | 19082440 18626508 |
MESH:D011471 |
Prostatic Neoplasms |
|
Vitamin E |
2.05 | 15084515 |
MESH:D012004 |
Rectal Neoplasms |
|
Fluorouracil |
4.08 | 15538739 16160472 18722050 18286688 |
MESH:D051437 |
Renal Insufficiency |
|
Cisplatin |
4.51 | 15464296 |
MESH:D015427 |
Reperfusion Injury |
|
Leucovorin |
4.62 | 17295595 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.93 | 18990726 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Cisplatin |
4.52 | 14601052 |
MESH:D012871 |
Skin Diseases |
|
Vitamin E |
2.46 | 18709164 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
5.59 | 19755658 10029692 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
5.59 | 16192470 |
MESH:D055752 |
Small Cell Lung Carcinoma |
|
Cisplatin |
5.48 | 15464296 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
4.83 | 20155912 2093021 |
MESH:D013274 |
Stomach Neoplasms |
|
Cisplatin |
4.83 | 15958060 17522103 18396642 |
MESH:D013274 |
Stomach Neoplasms |
|
Fluorouracil |
4.83 | 18567086 19084572 18396642 16951190 15786421 17172411 17522103 19015929 16424979 17498489 |
MESH:D013274 |
Stomach Neoplasms |
|
irinotecan |
4.83 | 15723263 |
MESH:D020521 |
Stroke |
|
Vitamin E |
3.58 | 16517955 |
MESH:D013736 |
Testicular Neoplasms |
|
Cisplatin |
4.72 | 15464296 17225452 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.04 | 12697716 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
4.82 | 19048282 |
MESH:D014062 |
Tongue Neoplasms |
|
Fluorouracil |
4.06 | 16280240 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
5.31 | 17053015 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Cisplatin |
5.31 | 17225452 12973940 15464296 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Cisplatin |
9.90 | 16803524 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Fluorouracil |
9.90 | 16803524 |
MESH:D014625 |
Vaginal Neoplasms |
|
Cisplatin |
4.71 | 15577323 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.73 | 12125929 |
MESH:D014839 |
Vomiting |
|
Cisplatin |
4.85 | 11897121 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.38 | 15886252 |